Trial Profile
A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Cyclophosphamide; Topotecan
- Indications CNS cancer; Diffuse intrinsic pontine glioma; Solid tumours
- Focus Adverse reactions
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 01 Apr 2020 Status changed from recruiting to completed.
- 31 May 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Apr 2020.